These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 9200676

  • 21. Comparative thermal and thermodynamic study of DNA chemically modified with antitumor drug cisplatin and its inactive analog transplatin.
    Lando DY, Chang CL, Fridman AS, Grigoryan IE, Galyuk EN, Hsueh YW, Hu CK.
    J Inorg Biochem; 2014 Aug; 137():85-93. PubMed ID: 24831492
    [Abstract] [Full Text] [Related]

  • 22. Marked dependence on carrier-ligand bulk but not on carrier-ligand chirality of the duplex versus single-strand forms of a DNA oligonucleotide with a series of G-Pt(II)-G intrastrand cross-links modeling cisplatin-DNA adducts.
    Beljanski V, Villanueva JM, Doetsch PW, Natile G, Marzilli LG.
    J Am Chem Soc; 2005 Nov 16; 127(45):15833-42. PubMed ID: 16277526
    [Abstract] [Full Text] [Related]

  • 23. Replacement of an NH(3) by an iminoether in transplatin makes an antitumor drug from an inactive compound.
    Leng M, Locker D, Giraud-Panis MJ, Schwartz A, Intini FP, Natile G, Pisano C, Boccarelli A, Giordano D, Coluccia M.
    Mol Pharmacol; 2000 Dec 16; 58(6):1525-35. PubMed ID: 11093793
    [Abstract] [Full Text] [Related]

  • 24. DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent.
    Brabec V, Kaspárková J, Vrána O, Nováková O, Cox JW, Qu Y, Farrell N.
    Biochemistry; 1999 May 25; 38(21):6781-90. PubMed ID: 10346899
    [Abstract] [Full Text] [Related]

  • 25. Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand.
    Kasparkova J, Vojtiskova M, Natile G, Brabec V.
    Chemistry; 2008 May 25; 14(4):1330-41. PubMed ID: 18022972
    [Abstract] [Full Text] [Related]

  • 26. Instability of the monofunctional adducts in cis-[Pt(NH3)2(N7-N-methyl-2-diazapyrenium)Cl](2+)-modified DNA: rates of cross-linking reactions in cis-platinum-modified DNA.
    Payet D, Gaucheron F, Sip M, Leng M.
    Nucleic Acids Res; 1993 Dec 25; 21(25):5846-51. PubMed ID: 8290343
    [Abstract] [Full Text] [Related]

  • 27. The stability of DNA intrastrand cross-links of antitumor transplatin derivative containing non-bulky methylamine ligands.
    Frybortova M, Novakova O, Brabec V.
    J Biol Inorg Chem; 2014 Oct 25; 19(7):1203-8. PubMed ID: 24986778
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Mass spectrometry of cis-diamminedichloroplatinum(II) adducts with the dinucleosidemonophosphates d(ApG), d(GpG) and d(TpC) in an ion trap.
    Hagemeister T, Linscheid M.
    J Mass Spectrom; 2002 Jul 25; 37(7):731-47. PubMed ID: 12125006
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Recognition of DNA interstrand cross-link of antitumor cisplatin by HMGB1 protein.
    Kasparkova J, Delalande O, Stros M, Elizondo-Riojas MA, Vojtiskova M, Kozelka J, Brabec V.
    Biochemistry; 2003 Feb 11; 42(5):1234-44. PubMed ID: 12564926
    [Abstract] [Full Text] [Related]

  • 38. Origins of the distortions in the base pair step adjacent to platinum anticancer drug-DNA adducts. Fundamental NMR solution studies utilizing right-handed cross-link models having 5'- and 3'-flanking residues.
    Saad JS, Natile G, Marzilli LG.
    J Am Chem Soc; 2009 Sep 02; 131(34):12314-24. PubMed ID: 19655752
    [Abstract] [Full Text] [Related]

  • 39. GA and AG sequences of DNA react with cisplatin at comparable rates.
    Monjardet-Bas V, Bombard S, Chottard JC, Kozelka J.
    Chemistry; 2003 Oct 06; 9(19):4739-45. PubMed ID: 14566881
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.